Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Volume XVIII No. 15 - November 7, 2011

Economics of Lab Testing to Be Challenged

BY ANY MEASURE, 2012 IS SHAPING UP TO BE A YEAR OF MAJOR CHANGE for healthcare and the clinical laboratory testing industry. Unfortunately, an early reading of the tea leaves indicates that the outcomes are not likely to be favorable for most clinical laboratories and anatomic pathology groups. Let’s start with one bright spot in …

Economics of Lab Testing to Be Challenged Read More »

To access this post, you must purchase The Dark Report.

Medicare Carrier Plans to Reject Molecular Claims

CEO SUMMARY: In September, Palmetto, a Medicare carrier serving California and seven other states, made public two draft local coverage determinations (LCDs) that revamp its coverage guidelines for molecular diagnostic tests (MDT) and laboratory-developed tests (LDT). All labs submitting claims to Palmetto would need to apply to Palmetto for each MDT or LDT it plans …

Medicare Carrier Plans to Reject Molecular Claims Read More »

To access this post, you must purchase The Dark Report.

Clin Lab Partners’ Strategy Is to Leverage Lab Data

CEO SUMMARY: At Clinical Laboratory Partners, the strategy is to create and deliver a growing suite of enhanced lab information services to client physicians and payers in the Connecticut market. It wants to differentiate itself from competing lab companies by packaging lab test data in ways that add value to both physicians and payers in …

Clin Lab Partners’ Strategy Is to Leverage Lab Data Read More »

To access this post, you must purchase The Dark Report.

Abbott Says It Will Split into Two Firms in 2012

FURTHER CHANGES ARE COMING to the in vitro diagnostics (IVD) marketplace. On October 19, Abbott Laboratories, Inc., announced that it would separate into two publicly-traded companies sometime in 2012. One business will be the medical devices and diagnostics business. It will have about $22 billion in annual sales. Of this total, about $4 billion comes from …

Abbott Says It Will Split into Two Firms in 2012 Read More »

To access this post, you must purchase The Dark Report.

At Kaiser Permanente, Real-Time Lab Results Are a Hit with Patients

CEO SUMMARY: Should patients be allowed to see their own lab test results when they are available to their physicians? Kaiser Permanente believes so. Since 2005, Kaiser Permanente has given members real-time access to most laboratory test results in their personal health record (PHR) on www.kp.org. In fact, viewing laboratory test results is the single …

At Kaiser Permanente, Real-Time Lab Results Are a Hit with Patients Read More »

To access this post, you must purchase The Dark Report.

Lab Testing, Pathology Is Fast-Growing in China

CEO SUMMARY: It was record attendance at the major pathology congress which took place in Hangzhou, China, last month. Because of the ongoing growth of China’s economy, the demand for healthcare—and for high-quality clinical lab and pathology testing—is rising at an accelerated pace. During his visit to the pathology congress and Chinese hospital labs, your …

Lab Testing, Pathology Is Fast-Growing in China Read More »

To access this post, you must purchase The Dark Report.

November 7, 2011 “Intelligence: Late Breaking Lab News”

Many experts were impressed when General Electric Co. ponied up $587 million to acquire pathology testing company Clarient, Inc., in October 2010. Now comes further insight behind this transaction. At an investment conference in Boston on November 3, John Dineen, CEO of GE Healthcare, told the audience that his company—currently generating revenue of $2.4 billion …

November 7, 2011 “Intelligence: Late Breaking Lab News” Read More »

To access this post, you must purchase The Dark Report.

;